Tradestie Institutional Equity Comparison Engine
TPST vs VVOS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TPST Overall Edge
TPST Captures Institutional Edge (3โ0 Pillars ยท 5โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tempest Therapeutics, Inc. Common Stock (TPST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TPST trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VVOS at N/M Forward P/E and -107.9% operating margin (+34.9% YoY). In options structure, TPST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
TPST N/M vs VVOS N/M Fwd P/E
Growth & Margin Winner
TPST
Op Margin 0.0% vs -107.9% ยท YoY +0.0% vs +34.9%
Momentum & Technical Winner
TPST
1Y -94.0% vs -97.7% ยท 52W Pos 0% vs 0%
Options & Structure Winner
TPST
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
TPST
NASDAQ
Tempest Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.29
-6.18% 1D
Market Cap
$6.1M
1M Return
-45.05%
1Y Return
-93.96%
Forward P/E
N/M
Unified AI Score
39.2 / 100
SELL
Tech 25.0
Fund 44.0
Flow 50.0
Mom 55.0
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TPST -93.96%
VVOS -97.71%
Spread: +3.75 pp (TPST Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | TPST Revenue | VVOS Revenue | TPST Op. Margin | VVOS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2017 | $0M | N/A | -28585.1% | N/A | TPST |
| FY2019 | N/A | $10M | N/A | -92.8% | VVOS |
| FY2020 | N/A | $10M | N/A | -92.1% | VVOS |
| FY2021 | N/A | $20M | N/A | -120.7% | VVOS |
| FY2022 | N/A | $20M | N/A | -156.2% | VVOS |
| FY2023 | N/A | $10M | N/A | -125.3% | VVOS |
| FY2024 | N/A | $20M | N/A | -74.3% | VVOS |
| FY2025 | N/A | $20M | N/A | -114.1% | VVOS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TPST | VVOS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1M | $1.9M | Larger Scale | Tie |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +34.9% | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | 0.0% | -107.9% | Higher Margin | TPST |
| Net Profit Margin Profitability | 0.0% | -121.8% | Higher Margin | TPST |
| Return on Equity (ROE) Capital Efficiency | -1797.6% | -8585.3% | Higher ROE | TPST |
| 52-Week Range Position Momentum | 0% ($0โ$9) | 0% ($0โ$3) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | 0.77ฮฒ ยท 85% Vol | 1.70ฮฒ ยท 111% Vol | Lower Realized Risk | TPST |
| Unified Institutional Score Composite Signal | 39.2 / 100 (SELL) | 36.4 / 100 (SELL) | Higher Composite | TPST |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TPST vs VVOS Buy Guide
TPST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TPST nor VVOS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.